RICHARD CALKINS: Open Payments
NPI 1790042406 · COPPERAS COVE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$792 in 43 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $1,106 · 2025 $792
Food & beverage: $792
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $144 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $111 |
| Exact Sciences Corporation | 5 | $96 |
| Lilly USA, LLC | 4 | $73 |
| ABBVIE INC. | 3 | $54 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $37 |
| Amgen Inc. | 2 | $32 |
| PFIZER INC. | 1 | $30 |
Products named: Kerendia, Cologuard Collection Kit, Ozempic, REXULTI, VRAYLAR, MOUNJARO, AIRSUPRA, XIFAXAN.
Industry payments across TX — which companies pay providers there.
